Screening for Neuroblastoma in Children

Craft AW Amineddine HA Scott JES Wagget J. The Northern Region Children's Malignant Disease Registry, 1968–1982: Incidence and survival. Br J Cancer 1987;56:853–8.

Stiller CA . Trends in neuroblastoma in Great Britain: Incidence and mortality, 1971–1990. Eur J Cancer 1993;29a:1008–12.

Craft AW Parker L. Poor prognosis neuroblastoma: Is screening the answer? Br J Cancer 1992;66:s96–101.

Tuchman M Ramnaraine MR Woods WG Krivit W. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 1987;79:203.

Sawada T Nakata T Takasugi N Mass screening for neuroblastoma in infants in Japan. Lancet. 1984;2:271–3.

Hanawa Y Tsukimoto I. The recent trend of childhood neuroblastoma death in Japan. In: Sawada T Matsumura T Kizaki Z , eds. Proceedings of the 3rd International symposium on neuroblastoma screening. Kyoto: Kyoto Prefectural University of Medicine, 1994:107–12.

Chamberlain J. Screening for neuroblastoma: A review of the evidence. J Med Screen 1994;1:169–75.

Woods WG Tuchman M Robison LL A population based study of the usefulness of screening for neuroblastoma. Lancet 1996;348:1682–7.

Bessho F. Effects of mass screening on age-specific incidence of neuroblastoma. Int J Cancer 1996;67:520–2.

Yamamoto K Hayashi Y Hanada R Mass screening and age-specific incidence of neuroblastoma in Saitama prefecture, Japan. J Clin Oncol 1995;13:2033–8.

Brodeur GM Nakagawara A. Molecular basis of heterogeneity of human neuroblastoma. Eur J Cancer 1995;31A:505–10.

Look AT Hayes A Shuster JJ Clnical relevance of tumour cell ploidy and N-myc gene amplification in childhood neuroblastoma: A pediatric oncology group study. J Clin Oncol 1991;9:581–91.

Maris JM White PS Beltinger CP Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 1995;55:4664–9.

Nakagawara A Arima-Nakagawara M Scavarda NJ Azar CG Cantor AB Brodeur AM . Association between high levels of expression of the TRK gene and favourable outcome in human neuroblastoma. N Engl J Med 1993;328:847–53.

Takeuchi LA Hachitanda Y Woods WG Screening for neuroblastoma in north America. Preliminary results of a pathology review from the Quebec project. Cancer 1995;76:2363–71.

Matsumura M Tsunoda A Nishi T Spontaneous regression of neuroblastoma detected by mass screening. Lancet 1991;338:447–8.

Hayashi Y Ohi R Yaoita S Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds. J Pediatr Surg 1995;30:467–70.

Schilling FH Berthold F Erttman R An epidemiological study to evaluate neuroblastoma screening at 12 months of age in Germany. 4th International symposium on neuroblastoma screening. Stuttgart, Germany, 1995.